Home LiteratureArticle Details
PMID: 173996 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Liver-cell adenomas associated with use of oral contraceptives.

The New England journal of medicine ·Vol. 294 ·No. 9 ·1976-02-26 ·Pages 470-2

Edmondson HA, Henderson B, Benton B

Abstract

During the past six years an increasing number of liver-cell adenomas in women were diagnosed, and we undertook a study of possible etiologic factors, including use of oral contraceptives, in 42 women. There was a significant difference between cases and matched controls in mean months of oral-contraceptive use: 73.4 as compared to 36.2 (P less than 0.001). The women with adenomas took mestranol-containing pills much more commonly than the controls (P less than 0.0001). Hemorrhage into the tumor was often associated with the onset of menstruation in women taking oral contraceptives. Long-term use of oral contraceptives, especially those containing a high total dose of steroids or mestranol as the synthetic estrogen, should be balanced against risks of side effects of the drugs.

MeSH Terms
Adult Carcinoma, Hepatocellular/chemically induced,pathology Contraceptives, Oral/adverse effects Ethinyl Estradiol/adverse effects Female Humans Liver/pathology Liver Neoplasms/chemically induced,pathology Mestranol/adverse effects Middle Aged Risk Time Factors
Chemicals
Contraceptives, Oral Ethinyl Estradiol Mestranol
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Edmondson H A
Henderson B
Benton B
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
Published
1976-02-26
Pages
470-2
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com